Kelly Grant

In this discussion, health reporter Kelly Grant and business of healthcare reporter Chris Hannay dive into the challenges that cancer patients face in accessing vital therapies like CAR-T drugs. They explore the complexities of Canada's drug approval and pricing processes, detailing why even approved treatments can take years to reach patients. The duo highlights the stark implications of these delays through personal stories, underscoring the urgent need for reforms to prioritize patient access over bureaucratic hurdles.